A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis

Clinical trial NCT06857227 · RECRUITING

Trial details

NCT number: NCT06857227
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2025-03-17
Primary completion: 2027-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.